Drug repositioning can accelerate discovery of pharmacological chaperones
A promising strategy for the treatment of genetic diseases, pharmacological chaperone therapy, has been proposed recently. It exploits small molecules which can be administered orally, reach difficult tissues such as the brain and have low cost. This strategy has a vast field of application. In orde...
Main Authors: | Hay Mele, Bruno, Citro, Valentina, Andreotti, Giuseppina, Cubellis, Maria Vittoria |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429356/ |
Similar Items
-
A thermodynamic assay to test pharmacological chaperones for Fabry disease☆
by: Andreotti, Giuseppina, et al.
Published: (2014) -
Therapy of Fabry disease with pharmacological chaperones: from in silico predictions to in vitro tests
by: Andreotti, Giuseppina, et al.
Published: (2011) -
The Analysis of Variants in the General Population Reveals That PMM2 Is Extremely Tolerant to Missense Mutations and That Diagnosis of PMM2-CDG Can Benefit from the Identification of Modifiers
by: Valentina Citro, et al.
Published: (2018-07-01) -
Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones
by: Cammisa, Marco, et al.
Published: (2013) -
Heterodimerization of Two Pathological Mutants Enhances the Activity of Human Phosphomannomutase2
by: Andreotti, Giuseppina, et al.
Published: (2015)